Distinct characteristics of transcellular transport between nicotine and tetraethylammonium in LLC-PK cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 2, 1998, Pages 676-680

  Takami, Kenji ^a   Saito, Hideyuki ^a   Okuda, Masahiro ^a   Takano, Mikihisa ^a   Inui, Ken Ichi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROMERCURIBENZENESULFONIC ACID; CIMETIDINE; NICOTINE; QUINIDINE SULFATE; TETRYLAMMONIUM;

ANIMAL CELL; APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CELL TRANSPORT; CONTROLLED STUDY; DRUG TRANSPORT; DRUG UPTAKE; KIDNEY EPITHELIUM; KIDNEY TUBULE EXCRETION; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; SMOKING; SWINE;

4-CHLOROMERCURIBENZENESULFONATE; ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; HYDROGEN-ION CONCENTRATION; LLC-PK1 CELLS; NICOTINE; NICOTINIC AGONISTS; SULFHYDRYL REAGENTS; SWINE; TETRAETHYLAMMONIUM;

EID: 0032412498     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. 1 and lipid solubility and the amounts excreted in urine of some tobacco alkaloids given to man. J Pharm Pharmacol 24:115-120.
2. 1 cells. J Am Soc Nephrol 5:75-84.
3. 1-methylnicotinamide uptake by brush border membrane vesicles from the dog kidney cortex. Can J Physiol Pharmacol 68: 467-475.
4. Bendayan R, Sullivan JT, Shaw C, Frecker RC and Sellers EM (1990b) Effect of cimetidine and ranitidine on the hepatic and renal elimination of nicotine in humans. Eur J Clin Pharmacol 38:165-169.
5. Benowitz NL and Jacob P III (1985) Nicotine renal excretion rate influences nicotine intake during cigarette smoking. J Pharmacol Exp Ther 234:153-155.
6. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
7. 1. Biochem J 227:199-203.
8. Kyerematen GA and Vesell ES (1991) Metabolism of nicotine. Drug Metab Rev 23:3-41.
9. 1 cells. J Am Soc Nephrol 1:1507-1515.
10. 1: Interaction with organic cation transporters in apical and basolateral membranes. J Pharmacol Exp Ther 276:1143-1148.
11. Plowchalk DR, Andersen ME and Debethizy JD (1992) A physiologically based pharmacokinetic model for nicotine disposition in the Sprague-Dawley rat. Toxicol Appl Pharmacol 116:177-188.
12. Rosenberg J, Benowitz NL, Jacob P and Wilson KM (1980) Disposition kinetics and effects of intravenous nicotine. Clin Pharmacol Ther 28:517-522.
13. 1. Am J Physiol 262:C59-C66.
14. Svensson CK (1987) Clinical pharmacokinetics of nicotine. Clin Pharmacokin 12: 30-40.
15. Takano M, Inui K, Okano T and Hori R (1985) Cimetidine transport in rat renal brush border and basolateral membrane vesicles. Life Sci 37:1579-1585.
16. Ullrich KJ, Rumrich G, David C and Fritzsch G (1993) Bisubstrates: substances that interact with renal contraluminal organic anion and organic cation transport systems. Pflügers Arch 425:280-299.
17. Wong LTY, Smyth DD and Sitar DS (1991) Interference with renal organic cation transport by (-)- and (+)-nicotine at concentrations documented in plasma of habitual tobacco smokers. J Pharmacol Exp Ther 261:21-25.
18. Yamaoka K, Tanigawara Y, Nakagawa T and Uno T (1981) A pharmacokinetic analysis program (MULTI) for microcomputer. J Pharmacobiodyn 4:879-885.